Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

FDA Issues Warning for Valsartan Contamination

FDA Warning

On June 13, 2018, the FDA issued a warning that alerted healthcare professionals to contamination in the product Valsartan. The contamination contained “impurities in certain commonly prescribed heart medicines.”[i]

Companies Involved

Some of the companies involved include Zhejiang Huayi Pharmaceutical Co., Ltd. (ZHP), which is a Chinese-based manufacturer, Torrent, Teva, and Aurobindo. The warning letter was specifically addressed to ZHP in 2018 about the cancer-causing impurities of the medication used to treat high blood pressure and heart failure.

Torrent, Teva, and Aurobindo all acted as suppliers from the manufacturer ZHP, all of which have had significant issues with cleanliness and testing. Even after the warning, Aurobindo claimed that its batch of products was not contaminated. The company performed very little testing and ignored the red flags in the results of the tests. Later, they admitted to the contamination, as did the other three entities.

Testing

The entities have sufficient testing supplies to do proper testing on the valsartan product, however, each chose not to do so.

Current State of Litigation

The current state of litigation is that discovery is about to close, and bellwether trials are set to begin shortly. The bellwether pool is currently about 28 plaintiffs. The bellwether depositions will be completed by October 1, 2021, and the bellwether physician depositions will be completed by November 4, 2021.

Injury Criteria

Cancer criteria are labeled into two different groups, Tier 1 and Tier 2. Under Tier 1, the cancer injury is to the stomach, small intestine, colon, esophagus, and liver. Under Tier 2, the cancer injury criteria are prostate, pancreas, leukemia, non-Hodgkin’s lymphoma, and multiple myeloma.

Risk Factors 

Risk factors that should be considered regardless of the cancer type are as follows: age of 65 to 81 diagnosed, alcohol use, BMI between 30 and 50, smoking, HPV, organ transplant, diabetic, previous exposure to radiation treatment, and manufacturing or industry workers.

[i]FDA warns API manufacturer involved in valsartan recall” https://www.fda.gov/news-events/press-announcements/fda-warns-api-manufacturer-involved-valsartan-recall-provides-information-patients-taking-these

 

 

PIP Insurance Coverage Florida: How it Works

PIP Insurance Coverage Florida: How it Works

Florida is one of 12 “no-fault” insurance states, requiring drivers to carry Personal Injury Protection (PIP) insurance on vehicles operated in the state. PIP insurance allows injured drivers to receive compensation for damages and medical expenses by utilizing their insurance coverage.

read more
An Update on PFAS Cases: New Contamination Sites in US

An Update on PFAS Cases: New Contamination Sites in US

Per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” have been a growing concern due to their persistence in the environment and potential health risks. Recent developments have highlighted new contamination sites and legal actions aimed at addressing these issues across the United States.

read more
Nursing Home Abuse: An Overview

Nursing Home Abuse: An Overview

Nursing home abuse involves the mistreatment, neglect, or exploitation of residents in long-term care facilities. This includes skilled nursing homes, assisted living facilities, and other institutions responsible for the care of elderly or vulnerable adults. Under both federal and state laws, these facilities are required to provide residents with a safe, dignified, and compassionate environment.

read more
Oxbryta Recall: What You Need to Know

Oxbryta Recall: What You Need to Know

Oxbryta is a prescription medication developed to help people with sickle cell disease (SCD). It works by improving the oxygen-carrying ability of red blood cells and reducing the complications that come with SCD, like pain crises and organ damage. While it’s been seen as a breakthrough for managing this condition, a recent recall has raised serious concerns about its safety.

read more
Wegovy Lawsuits and Media Attention Increase

Wegovy Lawsuits and Media Attention Increase

Wegovy is a concentrated form of semaglutide, a GLP-1 receptor drug approved by the FDA to manage type 2 diabetes and weight loss. Wegovy is similar to Ozempic and manufactured by the same drug company, Novo Nordisk. As we’ve reported recently, patients who suffered from gastroparesis and blindness after taking Ozempic are filing cases against the drug’s manufacturer.

read more
Depo-Provera Lawsuits: Do You Have a Case?

Depo-Provera Lawsuits: Do You Have a Case?

Depo-Provera is an injectable birth control that has been popular among women as an effective method to prevent pregnancy without having to take daily birth control pills. However, recent studies have indicated a link between Depo-Provera use and serious diseases like brain tumors, meningioma, and osteoporosis. We are now taking Depo-Provera lawsuit cases and will help you get the compensation you deserve for your injuries due to extended Depo-Provera use.

read more
Mass Tort Litigation Updates: September 2024

Mass Tort Litigation Updates: September 2024

When you’ve suffered an injury or illness due to a defective drug, our drug injury attorneys at Michael Brady Lynch Firm hold big pharmaceutical companies responsible for their negligent behavior and failure to warn consumers about dangerous products. In the past few months, there have been significant updates to several of the most prominent mass tort cases currently in litigation.

read more
×
What Our Clients Are Saying